KSHV ORF Antibodies

Santa Cruz Biotechnology delivers a wide array of KSHV ORF monoclonal antibodies for studying Kaposi's Sarcoma-associated Herpesvirus (KSHV) and its open reading frames (ORFs). KSHV ORF monoclonal antibodies support multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KSHV is a significant oncogenic virus associated with several malignancies, including Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman disease. The ORFs of KSHV play crucial roles in viral replication, immune evasion, and tumorigenesis, making them essential targets for understanding the virus's biology and its impact on human health. Research focused on KSHV ORFs can reveal key mechanisms of viral pathogenesis and identify potential therapeutic targets. Investigating KSHV ORFs helps scientists understand how the virus establishes infection and maintains latency in host cells. Understanding the molecular functions of individual KSHV ORFs contributes to developing targeted antiviral strategies. KSHV ORF monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of viral oncogenesis and develop new therapeutic approaches.